Highly selective novel amidation method

Details for Australian Patent Application No. 2005252111 (hide)

Owner Takeda Pharmaceutical Company Limited.

Inventors Sera, Misayo; Inagaki, Atsushi

Agent Griffith Hack

Pub. Number AU-A-2005252111

PCT Pub. Number WO2005/121133

Priority 2004-174417 11.06.04 JP

Filing date 10 June 2005

Wipo publication date 22 December 2005

International Classifications

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07C 51/06 (2006.01) Preparation of carboxylic acids or their salts, halides, or anhydrides - from carboxylic acid amides

C07C 231/02 (2006.01) Preparation of carboxylic acid amides

C07D 267/14 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/121133 Priority application(s): WO2005/121133

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005252112-Method for producing acetamidopyrrolidine derivative and intermediate compound thereof

2005252110-5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro2H-pyrido[2,3-D] pyrimidine derivatives and related compounds for the treatment of cancer